다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Immunity, v.6 no.4, 1997년, pp.479 - 490
Franzoso, Guido (Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, USA) , Carlson, Louise (Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, USA) , Scharton-Kersten, Tanya (Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, USA) , Shores, Elizabeth W (Division of Hematologic Products, Center for Biological Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA) , Epstein, Suzanne (Division of Cellular and Gene Therapies, Center for Biological Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA) , Grinberg, Alexander (Laboratory of Molecular Genetics, National Institute of Child Health, and Human Development, National Institutes of Health, USA) , Tran, Tom (Division of Hematologic Products, Center for Biological Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA) , Shacter, Emily (Division of Hematologic Products, Center for Biological Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA) , Leonardi, Antonio (Laboratory) , Anver, Miriam , Love, Paul , Sher, Alan , Siebenlist, Ulrich
AI-Helper
AbstractChromosomal translocations of bcl-3 are associated with chronic B cell lymphocytic leukemias. Previously, we have shown that Bcl-3, a distinct member of the IκB family, may function as a positive regulator of NF-κB activity, although its physiologic roles remained unknown. To u...
Immunity Ahearn 4 251 1996 10.1016/S1074-7613(00)80433-1 Disruption of the Cr2 locus results in a reduction in B-1a cells and an impaired B cell response to T-dependent antigen
Annu. Rev. Immunol Baeuerle 12 141 1994 10.1146/annurev.iy.12.040194.001041 Function and activation of NF-κB in the immune system
Annu. Rev. Immunol Baldwin 14 649 1996 10.1146/annurev.immunol.14.1.649 The NF-κB and I-κB proteins
Nature Beg 376 167 1995 10.1038/376167a0 Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
Genes. Dev Beg 9 2736 1995 10.1101/gad.9.22.2736 Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice
Curr. Opin. Immunol Biron 7 485 1995 10.1016/0952-7915(95)80093-X Effects of IL-12 on immune responses to microbial infections
Cell Bours 72 729 1993 10.1016/0092-8674(93)90401-B The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers
Nature Briskin 363 461 1993 10.1038/363461a0 MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1
Nature Burkly 373 531 1995 10.1038/373531a0 Expression of relB is required for the development of thymic medulla and dendritic cells
Mol. Cell. Biol Caamaño 16 1342 1996 10.1128/MCB.16.4.1342 Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-κB1 (p50) homodimers in vivo
Immunity Campbell 4 283 1996 10.1016/S1074-7613(00)80436-7 CD40 ligand is required for protective cell-mediated immunity to Leishmania major
Immunity Cao 2 223 1995 10.1016/1074-7613(95)90047-0 Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
Mol. Cell. Biol Chang 15 5180 1995 10.1128/MCB.15.9.5180 Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators
Cell Cosgrove 66 1051 1991 10.1016/0092-8674(91)90448-8 Mice lacking MHC class II molecules
J. Exp. Med Coutelier 165 64 1987 10.1084/jem.165.1.64 IgG2a restriction of murine antibodies elicited by viral infections
Science DeTogni 264 703 1994 10.1126/science.8171322 Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
Proc. Natl. Acad. Sci. USA Ettinger 93 13102 1996 10.1073/pnas.93.23.13102 Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-β receptor-IgG1 fusion protein
J. Immunol Ferguson 156 4576 1996 10.4049/jimmunol.156.12.4576 CD28 is required for germinal center formation
Nature Franzoso 359 339 1992 10.1038/359339a0 The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition
EMBO J Franzoso 12 3893 1993 10.1002/j.1460-2075.1993.tb06067.x The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites
Genes Dev Fujita 7 1354 1993 10.1101/gad.7.7b.1354 The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers
Infect. Agents Dis Gazzinelli 2 139 1993 Host resistance to Toxoplasma gondii
Proc. Natl. Acad. Sci. USA Gerondakis 93 3405 1996 10.1073/pnas.93.8.3405 Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor
Nature Grewal 378 617 1995 10.1038/378617a0 Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand
Curr. Topics Microbiol. Immunol Grouard 201 105 1995 Regulation of human B cell activation by follicular dendritic cell and T cell signals
J. Immunol Hakim 147 2310 1991 10.4049/jimmunol.147.7.2310 CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells
Proc. Natl. Acad. Sci. USA Hatada 89 2489 1992 10.1073/pnas.89.6.2489 The ankyrin repeat domains of the NF-κB precursor p105 and the proto-oncogene bcl-3 act as specific inhibitiors of NF-κB DNA binding
Cell Hibbs 83 301 1995 10.1016/0092-8674(95)90171-X Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease
Infect. Immun Hunter 62 2818 1994 10.1128/IAI.62.7.2818-2824.1994 Production of γ interferon by natural killer cells from Toxoplasma gondii-infected SCID mice
Oncogene Inoue 8 2067 1993 Bcl-3, a member of the IκB proteins, has distinct specificity towards the Rel family of proteins
Microbiol. Rev James 59 533 1995 10.1128/MMBR.59.4.533-547.1995 Role of nitric oxide in parasitic infections
Immunity Kamanaka 4 275 1996 10.1016/S1074-7613(00)80435-5 Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity
Immunity Kawabe 1 167 1994 10.1016/1074-7613(94)90095-7 The immune response in CD40-deficient mice
J. Exp. Med Kelsall 183 237 1996 10.1084/jem.183.1.237 Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch
Adv. Immunol Kelsoe 60 267 1995 10.1016/S0065-2776(08)60587-8 In situ studies of the germinal center reaction
Nature Kim 383 542 1996 10.1038/383542a0 The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes
Mol. Cell. Biol Klement 16 2341 1996 10.1128/MCB.16.5.2341 IκBα deficiency results in sustained NF-κB response and severe widespread dermatitis in mice
Genes Dev Kontgen 9 1965 1995 10.1101/gad.9.16.1965 Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
Curr. Topics Microbiol. Immunol Kosco-Vilbois 201 69 1995 Follicular dendritic cells
J. Exp. Med Lane 179 819 1994 10.1084/jem.179.3.819 B cell function in mice transgenic for mCTLA4-Hγ1
J. Immunol. Meth Leenen 174 5 1994 10.1016/0022-1759(94)90005-1 Markers of mouse macrophage development detected by monoclonal antibodies
J. Exp. Med LeHir 183 2367 1996 10.1084/jem.183.5.2367 Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling
J. Exp. Med Liu 184 1207 1996 10.1084/jem.184.4.1207 Mutant mice without B lymphocyte follicles
Annu. Rev. Immunol MacLennan 12 117 1994 10.1146/annurev.iy.12.040194.001001 Germinal centers
Nature Matsumoto 382 462 1996 10.1038/382462a0 Affinity maturation without germinal centres in lymphotoxin-α-deficient mice
Science Matsumoto 271 1289 1996 10.1126/science.271.5253.1289 Role of lymphotoxin and the type 1 TNF receptor in the formation of germinal centers
J. Immunol Michaelson 156 2828 1996 10.4049/jimmunol.156.8.2828 Regulation of 3′ IgH enhancers by a common set of factors, including κB-binding proteins
EMBO J Naumann 12 213 1993 10.1002/j.1460-2075.1993.tb05647.x The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-κB
Immunity Nishizumi 3 549 1995 10.1016/1074-7613(95)90126-4 Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice
Mol. Cell. Biol Nolan 13 3557 1993 10.1128/MCB.13.6.3557 The bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 in a phosphorylation-dependent manner
Cell Ohno 60 991 1990 10.1016/0092-8674(90)90347-H The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control
J. Exp. Med Pasparakis 184 1397 1996 10.1084/jem.184.4.1397 Immune and inflammatory responses in TNF-α-deficient mice
Nature Rickert 376 352 1995 10.1038/376352a0 Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice
J. Immunol Scharton-Kersten 157 4045 1996 10.4049/jimmunol.157.9.4045 In the absence of endogenous IFN-γ mice develop unimpaired IL-12 response to Toxoplasma gondii while failing to control acute infection
Nature Schubart 383 538 1996 10.1038/383538a0 B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation
Cell Sha 80 321 1995 10.1016/0092-8674(95)90415-8 Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Science Shores 266 1047 1994 10.1126/science.7526464 Role of TCR ζ chain in T cell development and selection
Annu. Rev. Cell. Biol Siebenlist 10 405 1994 10.1146/annurev.cb.10.110194.002201 Structure, regulation and function of NF-κB
J Immunol Snapper 156 183 1996 10.4049/jimmunol.156.1.183 B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching
Immunity Soong 4 263 1996 10.1016/S1074-7613(00)80434-3 Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection
Adv. Exp. Med. Biol Tew 329 461 1993 10.1007/978-1-4615-2930-9_77 Follicular dendritic cells in germinal center reactions
Annu. Rev. Immunol Trinchieri 13 251 1995 10.1146/annurev.iy.13.040195.001343 Interleukin-12
Cell Tybulewicz 65 1153 1991 10.1016/0092-8674(91)90011-M Neonatal lethality and lymphopenia in mice with homozygous disruption of the c-abl proto-oncogene
J. Histochem. Cytochem Van Vliet 34 883 1986 10.1177/34.7.3519751 Reticular fibroblasts in peripheral lymphoid organs identified by a monoclonal antibody
Genes Dev Verma 9 2723 1995 10.1101/gad.9.22.2723 Rel/NF-κB/IκB family
Immunol. Lett Vieira 40 157 1994 10.1016/0165-2478(94)90187-2 Infection with Leishmania major involves interleukin-12 production in vivo
Cell Weih 80 331 1995 10.1016/0092-8674(95)90416-6 Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family
Nature Wulczyn 358 597 1992 10.1038/358597a0 Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB
Immunity Xu 1 423 1994 10.1016/1074-7613(94)90073-6 Mice deficient for the CD40 ligand
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.